Piramal Pharma receives USFDA EIR for US facility; inspection closed with VAI

Piramal Pharma gets USFDA EIR with VAI for its Lexington plant, closing the 2025 inspection, shares edge up though stock remains 34% down over the past year.

Leave a Reply

Your email address will not be published. Required fields are marked *